Valeant to Discuss Philidor Transition in Call With Investors

Valeant Pharmaceuticals International Inc. will discuss its transition away from controversial pharmacy partner Philidor Rx Services LLC and provide an update on the company’s operations on a conference call Tuesday.

Chief Executive Officer Michael Pearson will host the call, along with Chief Financial Officer Robert Rosiello, Company Group Chairmen Ari Kellen and Deb Jorn, and Corporate Controller Tanya Carro, according to a statement Monday.

    Before it's here, it's on the Bloomberg Terminal. LEARN MORE